Skip to main content
Screener/Healthcare/Biotechnology

PLYX Polaryx Therapeutics, Inc. Common Stock

NASDAQ
$2.50-1.09 (-30.28%)
$2.20
$48.91
$2.33
$3.78
EPS (TTM)$-0.10
P/E Ratio-29.67
Dividend Yield
Market Cap$240.0M
Volume1.04M
Prev Close$3.60
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$2.5M$-0.05
Q4 '25$0-$1.5M$-0.03
Q3 '25$0-$1.4M$-0.01
Q2 '25$0-$1.0M$-0.01
Q1 '25$0-$5.1M$-0.03
Q4 '24$0-$723K$-0.00
Q3 '24$0-$771K$-0.00
Get Your Daily Market Recap